Surgical complications after minimally invasive oesophagectomy compared to open oesophagectomy for oesophageal cancer: A population-based, nationwide study in Finland




Sirviö, Ville E.J.; Räsänen, Jari V.; Helminen, Olli; Helmiö, Mika; Huhta, Heikki; Kallio, Raija; Koivukangas, Vesa; Kokkola, Arto; Lietzen, Elina; Meriläinen, Sanna; Pohjanen, Vesa-Matti; Rantanen, Tuomo; Ristimäki, Antti; Saarnio, Juha; Sihvo, Eero; Tyrväinen, Tuula; Uimonen, Mikko; Valtola, Antti; Kauppila, Joonas H.

PublisherElsevier

2025

EJSO - European Journal of Surgical Oncology

European Journal of Surgical Oncology

110093

51

7

0748-7983

1532-2157

DOIhttps://doi.org/10.1016/j.ejso.2025.110093

https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105004816246&origin=inward

https://research.utu.fi/converis/portal/detail/Publication/492312756



Introduction: Evidence on the safety of minimally invasive oesophagectomy (MIO) compared to open oesophagectomy (OO) in nationwide practice is lacking. The aim of this study was to compare surgical complications after MIO and OO in a nationwide, population-based, unselected cohort.

Materials and methods: Descriptive statistics were used to report complications and complication categories defined by the Oesophagectomy Complications Consensus Group, major complications, reoperations and 90-day mortality in all patients undergoing MIO and OO in Finland during 2007–2016. Main outcomes were compared using logistic regression, adjusting for confounding.

Results: Out of 699 patients, 295 (42 %) underwent MIO and 404 (58 %) underwent OO. Rates of anastomotic leakage (10 % vs 14 %, OR 0.47 (0.25–0.89)), intrathoracic abscesses (3 % vs 9 %, OR 0.13 (0.05–0.46)), major complications (35 % vs 47 %, OR 0.39 (0.25–0.60)) and reoperations (18 % vs 26 %, OR 0.43 (0.26–0.73)) were lower with MIO. Rates of pneumonia (16 % vs 27 %, OR 0.62 (0.38–1.03)), intra-abdominal abscesses (0.7 % vs 3.0 %, OR 0.20 (0.04–1.13)) and 90-day mortality (3.1 % vs 6.7 %, HR 0.48 (0.18–1.26)) were lower with MIO, but non-significant after adjustment. Pulmonary complications (36 % vs 46 %, OR 0.63 (0.41–0.96)) and infectious complications (11 % vs 22 %, OR 0.41 (0.23–0.73)) were less common with MIO, while rates of cardiac, gastrointestinal, urologic, thromboembolic, and neurologic complications were similar.

Conclusion: This study suggests a significant reduction in various surgical complications in patients undergoing MIO compared to OO and that implementing MIO into nationwide practice can be done safely.


This work was supported by research grants from Mary&Georg C. Ehrnrooth Foundation, Orion Research Foundation, Sigrid Jusélius Foundation, The Finnish Cancer Foundation and Päivikki and Sakari Sohlberg Foundation. The sources of funding did not have a role in any part of this research, including study design, data acquisition, data analysis and interpretation, manuscript preparation and submission for publication.


Last updated on 2025-11-06 at 08:48